U. Coskun Et Al. , "Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients," CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.137, no.3, pp.546-551, 2004
Coskun, U. Et Al. 2004. Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.137, no.3 , 546-551.
Coskun, U., Gunel, N., Sancak, B., Onuk, E., Bayram, M., & Cihan, A., (2004). Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients. CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.137, no.3, 546-551.
Coskun, UĞUR Et Al. "Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients," CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.137, no.3, 546-551, 2004
Coskun, UĞUR Et Al. "Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients." CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.137, no.3, pp.546-551, 2004
Coskun, U. Et Al. (2004) . "Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients." CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.137, no.3, pp.546-551.
@article{article, author={UĞUR COŞKUN Et Al. }, title={Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients}, journal={CLINICAL AND EXPERIMENTAL IMMUNOLOGY}, year=2004, pages={546-551} }